BioSpace News Archive

Revance to Participate in the Guggenheim Nantucket Therapeutics Conference

Revance to Participate in the Guggenheim Nantucket Therapeutics Conference.

September 21, 2022
·
2 min read
Helsinn presents novel data on Chlormethine gel at EORTC cutaneous lymphomas tumors group annual meeting

Helsinn presents novel data on Chlormethine gel at EORTC cutaneous lymphomas tumors group annual meeting.

September 21, 2022
·
7 min read
BioMidwest

BrightInsight and bioMérieux Announce Partnership to Launch Clinical Digital Solutions for Diagnostics

BrightInsight, Inc. and bioMérieux announced a partnership to develop and bring to market a Clinical Digital Solution for diagnostics enabling clinical decision support for disease areas across their diagnostic tests.

September 21, 2022
·
4 min read
Biotech Bay

BEST-SELLING OAXACAN MEZCAL LAUNCHES CONVITE® UNA’ TO HONOR BREAST CANCER AWARENESS MONTH

Convite®, the best-selling mezcal in Oaxaca, today announced the special release of Una’ – a pink-hued mezcal created to honor Breast Cancer Awareness Month in October.

September 21, 2022
·
4 min read
BioCapital

Latham BioPharm Group Announces Publication of Team Member’s Paper in Leading Scientific Journal

Latham Biopharm Group (LBG), in collaboration with researchers from RA Capital Management and Nostrum Biodiscovery, recently published a paper in the Journal of Chemical Information and Modeling (JCIM).

September 21, 2022
·
2 min read
Drug Development

CARsgen Presents North America Phase 2 Updates for CT053 BCMA CAR T at the 7th Annual CAR-TCR Summit

CARsgen Therapeutics Holdings Limited announces that at the 7th Annual CAR-TCR Summit, in Boston, Massachusetts, the Company gave an oral presentation on the North America Phase 2 clinical trial of zevorcabtagene autoleucel.

September 21, 2022
·
5 min read
AIM ImmunoTech to Present at the Virtual Investor Long COVID Event

AIM ImmunoTech Inc. today announced that it will participate in the Virtual Investor Long COVID Event on Wednesday, September 28, 2022 at 3:00 PM ET.

September 21, 2022
·
1 min read
Deals

Medtronic announces closing of public offering of €3.5 billion of senior notes

Medtronic plc (the “Company”) (NYSE: MDT) today announced that its wholly-owned subsidiary Medtronic Global Holdings S.C.A. ( “Medtronic Luxco”) has closed a registered public offering (the “Offering”) of €500,000,000 principal amount of 2.625% Senior Notes.

September 21, 2022
·
3 min read
Business

Evolus Concludes Certain Royalty Payments; Financial Profile Improves Significantly Starting in the Fourth Quarter of 2022

Evolus, Inc., a performance beauty company with a customer-centric approach focused on delivering breakthrough products, this month celebrated the conclusion of certain royalty payments that resulted from the 2021 settlement of litigation claims between the company and Medytox, Inc. and Allergan, Inc.

September 21, 2022
·
5 min read
Business

uLab™ hires Jeffrey Lord as Senior Vice President of Sales, North America

uLab Systems™ has announced that Jeffrey Lord has joined the company as senior vice president of sales for North America.

September 21, 2022
·
2 min read